Advanced company searchLink opens in new window

SHIRE PHARMACEUTICALS GROUP

Company number 02883758

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
18 Jul 2023 GAZ2(A) Final Gazette dissolved via voluntary strike-off
02 Jun 2023 TM02 Termination of appointment of Takeda Corporate Services Limited as a secretary on 31 May 2023
02 May 2023 GAZ1(A) First Gazette notice for voluntary strike-off
19 Apr 2023 DS01 Application to strike the company off the register
17 Apr 2023 RESOLUTIONS Resolutions
  • RES14 ‐ Re: the sum of usd 625,000 be capitalised / the sum of usd 29,426,000 be capitalised 30/03/2023
  • RES06 ‐ Resolution of reduction in issued share capital
  • RES13 ‐ Re: cancel share premium account 30/03/2023
  • RES10 ‐ Resolution of allotment of securities
26 Jan 2023 TM01 Termination of appointment of Jonathan Clark Neal as a director on 18 January 2023
10 Nov 2022 TM01 Termination of appointment of Mark Gibbons as a director on 8 November 2022
23 Aug 2022 AP01 Appointment of Ms Seyda Atadan Memis as a director on 1 August 2022
04 Jul 2022 CS01 Confirmation statement made on 23 June 2022 with no updates
21 Mar 2022 AP01 Appointment of Peter Michael Grubin as a director on 1 March 2022
21 Mar 2022 TM01 Termination of appointment of Kentaro Shirahata as a director on 1 March 2022
06 Jul 2021 CS01 Confirmation statement made on 23 June 2021 with no updates
17 Apr 2021 AA Full accounts made up to 31 March 2020
30 Nov 2020 AP01 Appointment of Mr Mark Gibbons as a director on 30 November 2020
30 Nov 2020 TM01 Termination of appointment of Nicholas Hugh Meryon Insall as a director on 30 November 2020
23 Jun 2020 CS01 Confirmation statement made on 23 June 2020 with updates
28 Apr 2020 CH04 Secretary's details changed for Shire Corporate Services Limited on 28 April 2020
04 Mar 2020 AA01 Current accounting period extended from 31 December 2019 to 31 March 2020
07 Feb 2020 CH01 Director's details changed for Mr Jonathan Clark Neal on 6 February 2020
05 Dec 2019 AUD Auditor's resignation
07 Oct 2019 AA Full accounts made up to 31 December 2018
05 Jul 2019 CS01 Confirmation statement made on 23 June 2019 with updates
29 May 2019 TM01 Termination of appointment of Damien Rodolphe Edmond Bailly as a director on 6 May 2019
23 Apr 2019 SH09 Allotment of a new class of shares by an unlimited company
13 Mar 2019 AP01 Appointment of Mr Jonathan Clark Neal as a director on 12 March 2019